Dr Joanna Kirman
Immunologist
Microbiology & Immunology
Otago University
New Zealand
Biography
BSc (Hons), University of Otago (1996) PhD (Pathology), University of Otago (1999), Infectious Diseases Group Leader, Malaghan Institute of Medical Research, Wellington (2002-2012)
Research Interest
Applied, cellular and molecular immunology, medical microbiology, vaccine immunology and technology.
Publications
-
Sustained in vivo depletion of splenic langerin+ CD8alpha+ dendritic cells is well-tolerated by lang-DTREGFP mice Prendergast KA, Osmond, TL, Ochiai S, Hermans IF, Kirman JR J Immunological Methods (2014) 406:104-
-
IL-1βR-dependent priming of antitumor CD4+ T cells and sustained antitumor immunity after peri-tumoral treatment with MSU and mycobacteria. Kuhn, S., Yang, J., Hyde, E. J., Harper, J. L., Kirman, J. R., & Ronchese, F. (2015). OncoImmunology, 4(10), e1042199.
-
The Memory Immune Response to Tuberculosis. Kirman JR, Henao-Tamayo MI, Agger EM. Microbiol Spectr. (2016) Dec;4(6).
